No. Delta 9 THC remains illegal in France under the Code de la santé publique, classified as a narcotic substance. While CBD products with <0.3% THC are permitted, Delta 9 THC—even in trace amounts—triggers strict prohibitions enforced by the Agence nationale de sécurité du médicament (ANSM). Recent 2026 draft amendments propose tighter controls on synthetic cannabinoids, reinforcing existing bans.
Key Regulations for Delta 9 THC in France
- Narcotic Classification: Delta 9 THC is listed under Annexe I of the Code de la santé publique, subjecting it to the same penalties as heroin or cocaine (up to 20 years imprisonment and €7.5M fines).
- CBD Threshold Enforcement: Products exceeding 0.3% Delta 9 THC face immediate seizure by Douanes françaises (French customs), with sellers liable for trafficking charges.
- Medical Exceptions: Only pharmaceutical-grade Delta 9 THC (e.g., Epidyolex) is permitted under ANSM authorization, reserved for rare epilepsy cases.
Local jurisprudence, such as the 2023 Cour de cassation ruling on CBD flower imports, underscores France’s zero-tolerance stance. The Mission interministérielle de lutte contre les drogues et les conduites addictives (MILDECA) actively monitors compliance, particularly for online sales targeting French consumers.